In this model, underweight BMI was independently associated with a lower odds of response compared with normal BMI (OR 0.24, 95% CI 0.075–0.77; P = 0.02) whereas obesity categories showed lower efficacy although these differences did not achieve significance with the exception of severe obesity (BMI ≥ 35: OR 0.72, 95% CI 0.53–0.98) (Table 3 ).
← all excerpts
Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis.
1
—
—